IAS 9 Paris 2017

9th IAS Conference on HIV Science (IAS 2017)

24 January 2018. Related: Conference reports.

Dolutegravir outperforms lopinavir/ritonavir second-line: interim results from the DAWNING study

24 January 2018. Related: Conference reports, Antiretrovirals, Treatment access, Treatment strategies.

Reduced-dose darunavir is safe and effective in switch study

24 January 2018. Related: Conference reports, Antiretrovirals.

Preliminary results on dolutegravir use in pregnancy are reassuring

24 January 2018. Related: Conference reports, PMTCT and maternal health.

Low dose efavirenz (EFV400) can be used during pregnancy

24 January 2018. Related: Conference reports, PMTCT and maternal health.

Screening HIV positive pregnant women for TB in South Africa increased detection by 10-fold

24 January 2018. Related: Conference reports, PMTCT and maternal health, Women's health, Transmission, Prevention.

Earlier ART reduces infant mortality in South Africa but risk of death and loss to follow up still high

24 January 2018. Related: Conference reports, Paediatric care.